Search Results 471-480 of 17855 for monoclonal antibody

  1. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...

  2. BRCA Gene Test Clinical Trials - Mayo Clinic Research

    Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...

  3. Infliximab-axxq (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab-axxq is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

  4. Adinarayana Kunamneni, Ph.D. - Mayo Clinic Faculty Profiles

    Kunamneni develops multiple technology platforms to discover new single-chain variable fragment and monoclonal antibodies. ... antibody humanization and antibody ...

  5. Ravulizumab-cwvz (intravenous route) - Side effects & uses - Mayo Clinic

    Ravulizumab-cwvz injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...

  6. Dinutuximab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  7. Oncology (Medical) - Clinical trials

    ... antibodies against the study drug (which ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread.

  8. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  9. Oncology (Medical) - Clinical trials

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  10. Medical Research & Education - Mayo Clinic News Network

    Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds. Jay Furst. June 27, 2022.